<?xml version="1.0" encoding="UTF-8"?>
<fig id="f0005" fig-type="figure" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>LINC00466 facilitates PPP1R14B expression by inhibiting miR-137. (
   <bold>A</bold>) VENNY plot of the predicted target mRNAs of miR-137; (
   <bold>B</bold>) Differential expression of miR-137 in Tumor and Normal of TCGA-GBM/LGG; (
   <bold>C</bold>) The survival curves of PPP1R14B expression level to the prognosis of patients, high-expression group was defined as red line, and low-expression group was defined as blue line; (
   <bold>D</bold>) The expression level of PPP1R14B in glioma tissues and adjacent normal tissues; (
   <bold>E</bold>) The target binding site between miR-137 and PPP1R14B and the results of dual luciferase assay; (
   <bold>F</bold>) The co-immunoprecipitation of miR-137 and PPP1R14B in T98G cells was evaluated by RIP assay; (
   <bold>G</bold>) The relative expression levels of LINC00466, miR-137 and PPP1R14B in different groups of T98G cells.
  </p>
 </caption>
 <graphic content-type="print-only" xlink:href="OTT-14-1147-g0005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
